| Nov 22, 2024 |
Nov 22, 2024 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
20.0
|
-6,586
|
-5.95%
|
✗
|
$268.4K |
| Dec 14, 2023 |
Dec 15, 2023 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
20.0
|
-7,598
|
-60.78%
|
✗
|
$311.9K |
| Dec 13, 2023 |
Dec 15, 2023 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
20.0
|
-22,000
|
-12.24%
|
✗
|
$878.9K |
| Nov 23, 2022 |
Nov 28, 2022 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
22.5
|
-4,114
|
-4.61%
|
✗
|
$142.1K |
| Mar 17, 2021 |
Jun 4, 2021 |
Xenon Pharmaceuticals Inc.
|
Director |
Buy |
60.0
|
+100
|
0.42%
|
✗
|
$1.9K |
| Jun 14, 2018 |
Jun 15, 2018 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
26.3
|
-2,856
|
-8.72%
|
✗
|
$23.7K |
| Aug 10, 2017 |
Aug 14, 2017 |
Xenon Pharmaceuticals Inc.
|
Director |
Buy |
91.3
|
+7,500
|
44.05%
|
✗
|
$20.8K |
| Aug 8, 2017 |
Aug 10, 2017 |
Xenon Pharmaceuticals Inc.
|
Director |
Buy |
91.3
|
+5,000
|
41.57%
|
✗
|
$15K |
| Dec 6, 2016 |
Dec 8, 2016 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
26.3
|
-4,403
|
-26.80%
|
✗
|
$34.8K |
| Nov 4, 2015 |
Nov 6, 2015 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
26.3
|
-1,955
|
-32.36%
|
✗
|
$16.3K |
| Jan 7, 2015 |
Jan 21, 2015 |
Xenon Pharmaceuticals Inc.
|
Director |
Sell |
26.3
|
-953
|
-27.25%
|
✗
|
$21.2K |
| Aug 7, 2014 |
Aug 8, 2014 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
5.0
|
-20,000
|
-96.61%
|
✓
|
$2M |
| Jul 14, 2014 |
Jul 15, 2014 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
5.0
|
-29,700
|
-90.52%
|
✓
|
$2.6M |
| May 9, 2014 |
May 13, 2014 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
5.0
|
-30,000
|
-97.71%
|
✓
|
$2.2M |
| Oct 1, 2013 |
Oct 4, 2013 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
7.5
|
-20,000
|
-99.43%
|
✓
|
$978.4K |
| Jul 1, 2013 |
Jul 2, 2013 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
5.0
|
-40,000
|
-99.71%
|
✓
|
$1.2M |
| Apr 12, 2013 |
Apr 16, 2013 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
7.5
|
-10,000
|
-98.86%
|
✓
|
$300K |
| Apr 1, 2013 |
Apr 3, 2013 |
Pacira BioSciences, Inc.
|
Chief Medical Officer |
Sell |
7.5
|
-30,000
|
-99.62%
|
✓
|
$844.6K |